TipRanks
Advertisement
Advertisement

INMB Stock Latest News

Inmune Bio Adds Strategic Directors to Support Commercialization
Company AnnouncementsInmune Bio Adds Strategic Directors to Support Commercialization
3d ago
8K
INMB
INmune Bio submits two regulatory packages to EMA for Ebstrocel
PremiumThe Fly
INmune Bio submits two regulatory packages to EMA for Ebstrocel
23d ago
INMB
INmune Bio Earnings Call Highlights De-Risking, Cash Risks
PremiumCompany Announcements
INmune Bio Earnings Call Highlights De-Risking, Cash Risks
26d ago
INMB
Jason McCarthy Reiterates Buy on INmune Bio, Keeps $8 Price Target Amid Advancing Clinical and Regulatory Milestones
PremiumRatings
Jason McCarthy Reiterates Buy on INmune Bio, Keeps $8 Price Target Amid Advancing Clinical and Regulatory Milestones
1M ago
INMB
INmune Bio Strengthens Cash Runway With R&D Rebates
PremiumCompany Announcements
INmune Bio Strengthens Cash Runway With R&D Rebates
2M ago
8K
INMB
INmune Bio receives $4.6M in rebates from Australia, UK
PremiumThe FlyINmune Bio receives $4.6M in rebates from Australia, UK
2M ago
INMB
INmune Bio processes first umbilical cord tissue at CGT Catapult
Premium
The Fly
INmune Bio processes first umbilical cord tissue at CGT Catapult
2M ago
INMB
Strengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
Premium
Ratings
Strengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
2M ago
INMB
INmune Bio Executes Warrant Inducement and Extension Agreement
PremiumCompany Announcements
INmune Bio Executes Warrant Inducement and Extension Agreement
3M ago
8K
INMB
INmune Bio advances CORDStrom platform patent application in the U.S.
PremiumThe Fly
INmune Bio advances CORDStrom platform patent application in the U.S.
3M ago
INMB
INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan
PremiumThe Fly
INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan
3M ago
INMB
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
PremiumCompany Announcements
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
3M ago
8K
INMB
INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting
PremiumThe FlyINmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting
3M ago
INMB
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
Premium
Company Announcements
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
3M ago
8K
INMB
Maintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
Premium
Ratings
Maintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
4M ago
INMB
INmune Bio reports positive Phase 2 MRI results
PremiumCompany Announcements
INmune Bio reports positive Phase 2 MRI results
4M ago
8K
INMB
INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
PremiumThe Fly
INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
4M ago
INMB
Inmune Bio Charts Regulatory Path Amid Cash Constraints
PremiumCompany Announcements
Inmune Bio Charts Regulatory Path Amid Cash Constraints
4M ago
INMB
INmune Bio publishes MINDFuL trial results in NPJ Dementia
PremiumThe Fly
INmune Bio publishes MINDFuL trial results in NPJ Dementia
4M ago
INMB
INmune Bio Receives FDA Fast Track for XPro
PremiumCompany AnnouncementsINmune Bio Receives FDA Fast Track for XPro
4M ago
8K
INMB
INmune Bio receives fast track designation from FDA for XPro
Premium
The Fly
INmune Bio receives fast track designation from FDA for XPro
4M ago
INMB
Inmune Bio Advances CORDStrom Amid Funding Pressures
Premium
Company Announcements
Inmune Bio Advances CORDStrom Amid Funding Pressures
4M ago
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >